Mechanisms and therapeutic advances of gut metabolites in the regulation of neuroimmune inflammatory diseases - Takeaways - MDSpire

Mechanisms and therapeutic advances of gut metabolites in the regulation of neuroimmune inflammatory diseases

  • By

  • Xiaodan Shen

  • Caiji Zheng

  • Renyong Lin

  • Juan Wang

  • Zheng Chen

  • June 2, 2026

  • 0 min

Share

  • 1

    Gut-derived metabolites are crucial signaling intermediaries that influence CNS responses and neuroimmune inflammatory disorders.

  • 2

    Short-chain fatty acids (SCFAs) promote regulatory T-cell differentiation and provide neuroprotection by inhibiting microglial activation.

  • 3

    Bile acids have a dual role, activating anti-inflammatory pathways while certain types can provoke neuroinflammation.

  • 4

    Dysbiosis of gut microbiota is linked to neuroimmune inflammatory diseases, characterized by metabolite imbalances and pro-inflammatory immune responses.

  • 5

    Novel therapies targeting the gut-immune-brain axis include immune-centric and microbiota-centric approaches to restore balance and mitigate neuroinflammation.

Original Source(s)

Mechanisms and therapeutic advances of gut metabolites in the regulation of neuroimmune inflammatory diseases

  • by Xiaodan Shen, Caiji Zheng, Renyong Lin, Juan Wang, Zheng Chen

  • June 2, 2026

Related Content

Digital life stories: Navigating together – an observation study of healthcare professionals and people living with dementia

Editorial: Transforming dementia caregiving through assistive technologies

Home Health Value-Based Purchasing and Postacute Home Health Visits Among Older Adults With Dementia